,South Africa: Clinical Trial Liability Insurance Guideline
Strengthening Risk Coverage & Participant Protection
Effective from March 27, 2026SAHPRA | Pharmaceuticals | Regulatory AffairsChina: Registration Service Platform Launch
Advancing Digital Drug Registration & Public Access
Effective from March 30, 2026NMPA | Pharmaceuticals | Regulatory AffairsChina: Conditional Drug Approval System Update
Accelerating Access for Critically Ill Patients
Effective from March 30, 2026NMPA | Pharmaceuticals | Regulatory AffairsMexico's Regulation: COFEPRIS Eliminates the Review of Notices as Part of Administrative Simplification - Drugs
COFEPRIS announces the elimination of mandatory review for certain Notices to streamline processes and reduce administrative burdens as part of its digital transformation efforts.
COFEPRIS | Pharmaceuticals | Country Regulatory AffairsMexico's Regulation: The National Center for Pharmacovigilance and Technovigilance (CENAFyT) is Created -Drugs
Establishment of CENAFyT to enhance the coordination, monitoring, and reporting of medicine safety through improved pharmacovigilance in Mexico.
COFEPRIS | Pharmaceuticals | Country Regulatory Affairs
Consult
